You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

SORILUX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sorilux patents expire, and what generic alternatives are available?

Sorilux is a drug marketed by Mayne Pharma and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-nine patent family members in thirteen countries.

The generic ingredient in SORILUX is calcipotriene. There are twelve drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the calcipotriene profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sorilux

A generic version of SORILUX was approved as calcipotriene by FOUGERA PHARMS on May 6th, 2008.

  Try a Trial

Summary for SORILUX
International Patents:29
US Patents:2
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 51
Clinical Trials: 5
Patent Applications: 5,629
Drug Prices: Drug price information for SORILUX
What excipients (inactive ingredients) are in SORILUX?SORILUX excipients list
DailyMed Link:SORILUX at DailyMed
Drug patent expirations by year for SORILUX
Drug Prices for SORILUX

See drug prices for SORILUX

Recent Clinical Trials for SORILUX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Skin Sciences, PLLCPhase 4
Tulane UniversityEarly Phase 1
Mayne Pharma International Pty LtdEarly Phase 1

See all SORILUX clinical trials

Pharmacology for SORILUX
Drug ClassVitamin D Analog

US Patents and Regulatory Information for SORILUX

SORILUX is protected by five US patents.

Patents protecting SORILUX

Vitamin formulation
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: USE OF A CALCIPOTRIENE CONTAINING FOAM FOR THE TREATMENT OF PSORIASIS

Vitamin formulation
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: USE OF CALCIPOTRIENE FOAM FOR THE TOPICAL TREATMENT OF PLAQUE PSORIASIS IN PATIENTS AGED 4 YEARS AND OLDER

Vitamin formulation
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: USE OF A CALCIPOTRIENE CONTAINING FOAM FOR THE TREATMENT OF PSORIASIS

Vitamin formulation
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: USE OF CALCIPOTRIENE FOAM FOR THE TOPICAL TREATMENT OF PLAQUE PSORIASIS IN PATIENTS AGED 18 YEARS AND OLDER

Vitamin formulation
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: USE OF CALCIPOTRIENE FOAM FOR THE TOPICAL TREATMENT OF PLAQUE PSORIASIS IN PATIENTS AGED 4 YEARS AND OLDER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma SORILUX calcipotriene AEROSOL, FOAM;TOPICAL 022563-001 Oct 6, 2010 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Mayne Pharma SORILUX calcipotriene AEROSOL, FOAM;TOPICAL 022563-001 Oct 6, 2010 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SORILUX

See the table below for patents covering SORILUX around the world.

Country Patent Number Title Estimated Expiration
Poland 2526930 ⤷  Try a Trial
Spain 2431330 ⤷  Try a Trial
Poland 1917072 ⤷  Try a Trial
Canada 2611147 PREPARATION VITAMINEE (VITAMIN FORMULATION) ⤷  Try a Trial
European Patent Office 1112062 COMPOSITION DE MOUSSE (MOUSSE COMPOSITION) ⤷  Try a Trial
European Patent Office 2526930 Préparation vitaminée (Vitamin formulation) ⤷  Try a Trial
Austria 381315 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.